Hypoglycaemia as a function of HbA1c, in type 2 diabetes: insulin glargine 300 U/ml in a patient-level meta-analysis of EDITION 1, 2 and 3

被引：0
|
作者：
Choudhary, P. [1 ]
Bonadonna, R. [2 ]
Yale, J. -F. [3 ]
Brulle-Wohlhueter, C. [4 ]
Boelle-Le Corfec, E. [4 ]
Bailey, T. S. [5 ]
机构：
[1] Kings Coll London, Diabet & Nutr Sci, London, England
[2] Univ Parma, Dept Clin & Expt Med, Parma, Italy
[3] McGill Univ, Montreal, PQ, Canada
[4] Sanofi, Paris, France
[5] Adv Metab Care & Res Inst, Escondido, CA USA
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
10
引用
收藏
页码：S6 / S7
页数：2
相关论文
共 50 条
  • [21] Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta-analysis
    Joshi, Shashank R.
    Singh, Gursharan
    Marwah, Ashwani
    Mittra, Shivani
    Suvarna, Viraj R.
    Athalye, Sandeep N.
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1589 - 1606
  • [22] Baseline HbA1c predicts the likelihood of reaching the 7.0% HbA1c target with structured titration of add-on insulin glargine: patient-level analysis of 12 studies in type 2 diabetes mellitus
    Zhou, R.
    Vlajnic, A. A.
    Orloff, D.
    Rosenstock, J.
    Riddle, M.
    [J]. DIABETOLOGIA, 2009, 52 : S350 - S350
  • [23] Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis)
    Roussel, Ronan
    d'Emden, Michael C.
    Fisher, Miles
    Javier Ampudia-Blasco, F.
    Stella, Peter
    Bizet, Florence
    Cali, Anna M. G.
    Wysham, Carol H.
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (02): : 448 - 452
  • [24] Glycaemic variability and risk for hypoglycaemia on insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes
    Kovatchev, B.
    Meng, Z.
    Breton, M.
    Leroy, B.
    Cali, A.
    Perfetti, R.
    [J]. DIABETOLOGIA, 2017, 60 : S36 - S37
  • [25] New insulin glargine 300 U/ml: glycaemic control and hypoglycaemia in insulin-naive people with type 2 diabetes mellitus (EDITION 3)
    Bolli, G. B.
    Riddle, M. C.
    Bergenstal, R. M.
    Ziemen, M.
    Sestakauskas, K.
    Goyeau, H.
    Home, P. D.
    [J]. DIABETOLOGIA, 2014, 57 : S387 - S388
  • [26] New insulin glargine 300 U/mL: glycaemic control and hypoglycaemia in Japanese people with type 1 diabetes mellitus (EDITION JP 1)
    Matsuhisa, M.
    Koyama, M.
    Cheng, X.
    Shimizu, S.
    Hirose, T.
    [J]. DIABETOLOGIA, 2014, 57 : S400 - S400
  • [27] Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
    Kovatchev, Boris
    Meng, Zhaoling
    Cali, Anna M. G.
    Perfetti, Riccardo
    Breton, Marc D.
    [J]. DIABETES THERAPY, 2020, 11 (06) : 1293 - 1302
  • [28] Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100 U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy
    Owens, David R.
    Traylor, Louise
    Mullins, Peter
    Landgraf, Wolfgang
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 124 : 57 - 65
  • [29] Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
    Lau, Ip Tim
    Lee, Ka Fai
    So, Wing Yee
    Tan, Kathryn
    Yeung, Vincent Tok Fai
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2017, 10 : 273 - 284
  • [30] Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
    Boris Kovatchev
    Zhaoling Meng
    Anna M. G. Cali
    Riccardo Perfetti
    Marc D. Breton
    [J]. Diabetes Therapy, 2020, 11 : 1293 - 1302
12345